Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan Atar

Showing results (31-40 of 405) with videos related to

Pageof 41
Sort By:
Thrombosis and Haemostasis|January 7, 2021
Use of Non-vitamin K Antagonist Oral Anticoagulants for Stroke Prevention across the Stroke Spectrum: Progress and ProspectsA John Camm, Dan Atar
Scandinavian Cardiovascular Journal : SCJ|May 10, 2007
Cholesterol and peripheral vascular disease: a neglected topic?Dan Atar, Jørgen J Jørgensen
The American Journal of Cardiology|January 16, 2007
Assessment of bleeding events in clinical trials--proposal of a new classificationVictor L Serebruany, Dan Atar
Thrombosis and Haemostasis|July 28, 2012
Viewpoint: Central adjudication of myocardial infarction in outcome-driven clinical trials--common patterns in TRITON, RECORD, and PLATO?Victor L Serebruany, Dan Atar
Advances in Cardiology|August 22, 2012
Introduction. Antiplatelet therapy in ACS and A-FibVictor L Serebruany, Dan Atar
European Journal of Internal Medicine|May 3, 2021
The Times They Are A-Changin´: Antithrombotic strategies in patients with acute coronary syndrome undergoing coronary stenting who have concomitant atrial fibrillationTrygve S Hall, Dan Atar
European Heart Journal. Cardiovascular Pharmacotherapy|July 28, 2018
Peripheral arterial disease and limb salvage: a new arena for the cardiologistBasil S Lewis, Dan Atar
European Heart Journal|December 17, 2009
The PLATO trial: do you believe in magic?Victor L Serebruany, Dan Atar
Cardiology|November 30, 2017
Type 2 Diabetes and Heart Failure - More Scrutiny Wanted!Dan Atar, Kristian F Hanssen
Advances in Cardiology|August 22, 2012
ConclusionDan Atar, Victor L Serebruany
Pageof 41

Showing results (31-40 of 405) with videos related to

Sort By:
Pageof 41
Thrombosis and Haemostasis|January 7, 2021
Use of Non-vitamin K Antagonist Oral Anticoagulants for Stroke Prevention across the Stroke Spectrum: Progress and ProspectsA John Camm, Dan Atar
Scandinavian Cardiovascular Journal : SCJ|May 10, 2007
Cholesterol and peripheral vascular disease: a neglected topic?Dan Atar, Jørgen J Jørgensen
The American Journal of Cardiology|January 16, 2007
Assessment of bleeding events in clinical trials--proposal of a new classificationVictor L Serebruany, Dan Atar
Thrombosis and Haemostasis|July 28, 2012
Viewpoint: Central adjudication of myocardial infarction in outcome-driven clinical trials--common patterns in TRITON, RECORD, and PLATO?Victor L Serebruany, Dan Atar
Advances in Cardiology|August 22, 2012
Introduction. Antiplatelet therapy in ACS and A-FibVictor L Serebruany, Dan Atar
European Journal of Internal Medicine|May 3, 2021
The Times They Are A-Changin´: Antithrombotic strategies in patients with acute coronary syndrome undergoing coronary stenting who have concomitant atrial fibrillationTrygve S Hall, Dan Atar
European Heart Journal. Cardiovascular Pharmacotherapy|July 28, 2018
Peripheral arterial disease and limb salvage: a new arena for the cardiologistBasil S Lewis, Dan Atar
European Heart Journal|December 17, 2009
The PLATO trial: do you believe in magic?Victor L Serebruany, Dan Atar
Cardiology|November 30, 2017
Type 2 Diabetes and Heart Failure - More Scrutiny Wanted!Dan Atar, Kristian F Hanssen
Advances in Cardiology|August 22, 2012
ConclusionDan Atar, Victor L Serebruany
Pageof 41